V

Voyager Therapeutics

D
VYGR
USD
-0.18
(-2.4759%)
Market Closed
19,867.00
Volume
-1.17
EPS
-
Div Yield
26.259
P/E
386,640,770.86
Market Cap
Today
-2.4759%
1 Week
3.655%
1 Month
4.418%
6 Months
-19.248%
12 Months
3.807%
Year To Date
-15.995%
All Time
0%

Title:
Voyager Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
Do you need help or have a question?